Return to search

A Case-Control Study of ATM and Susceptibility to Squamous Cell Carcinoma of the Head and Neck

The American Cancer Society estimates that >500,000 new cases of squamous cell carcinomas of the head and neck (SCCHN) are diagnosed each year. Although the incidence varies widely around the world, it is especially high in developing countries and is positively associated with higher rates of exogenous risk factors including, smoking, alcohol use, and viral infection. But, only a fraction of the people in these high-risk groups will develop the disease. Treatment times tend to be long and costly with survival rates averaging 50%, one of the lowest for the major cancers. Therefore, further work is needed to aid in our understanding of genetic and environmental risk factors, as well as the underlying biology of SCCHN. To further assess the etiology of SCCHN, the study used the approach of examining one candidate gene, the Ataxia Telangiectasia Mutated gene (ATM), located at 11q22.3 and functioning in the DNA damage response/repair pathway. Compared to other cancers, SCCHN tumors exhibit a very high rate of chromosomal instability, often showing amplification of chromosome 11q13 and loss of 11q22-qter. We hypothesized that SCCHN patients (cases) have a higher incidence of germline alterations in ATM than controls. Three hundred cases and 360 controls were genotyped for nine ATM tag-SNPs and supplemented with one splice-site SNP. Logistic regression analysis showed that two SNPs (rs611646 and rs373759) were associated with increased risk of developing SCCHN: P = 0.012 and P = 0.025, respectively. In SNP rs611646, the TT genotype was more common in cases than controls (45 versus 32%) while the AA and AT genotypes were less common in cases than controls (18 versus 21% and 37 versus 46%, respectively). In SNP rs373759, the CC genotype was more common in cases than controls (56 versus 48%) with the CT type being less common in cases than controls (29 versus 40%). Genetic studies such as this could have a public health impact by identifying markers for early detection of SCCHN, for predicting prognosis, for therapy and drug development, and aiding in the development of new, individualized treatment strategies.

Identiferoai:union.ndltd.org:PITT/oai:PITTETD:etd-06132007-092438
Date25 September 2007
CreatorsGrams, Sarah Elizabeth
ContributorsSusanne Gollin, Emanuela Taioli, Eleanor Feingold, Robert Ferrell
PublisherUniversity of Pittsburgh
Source SetsUniversity of Pittsburgh
LanguageEnglish
Detected LanguageEnglish
Typetext
Formatapplication/pdf
Sourcehttp://etd.library.pitt.edu/ETD/available/etd-06132007-092438/
Rightsrestricted, I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to University of Pittsburgh or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.

Page generated in 0.0024 seconds